Skip to main content

Stromal Upper GI Tract Neoplasms

  • Chapter
Upper Gastrointestinal Surgery

Part of the book series: Springer Specialist Surgery Series ((SPECIALIST))

  • 1375 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Goulden T, Stout AP. Smooth muscle tumors of the gastrointestinal tract and retroperitoneal tissues. Surg Gynecol Obstet 1941;73:784–8.

    Google Scholar 

  2. Welsh RA, Meyer AT. Ultrastructure of gastric leiomyoma. Arch Pathol Lab Med 1969;87:71–81.

    Google Scholar 

  3. Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol 1983;7:507–19.

    PubMed  Google Scholar 

  4. Appelman HD. Smooth muscle tumors of the gastrointestinal tract. What we know now that Stout didn’t know. Am J Surg Pathol 1986;10(Suppl 1):83–99.

    PubMed  Google Scholar 

  5. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998;152:1259–69.

    PubMed  Google Scholar 

  6. Chan JK. Mesenchymal tumors of the gastrointestinal tract: a paradise for acronyms (STUMP, GIST, GANT, and now GIPACT), implication of c-KIT in genesis, and yet another of the many emerging roles of the interstitial cell of Cajal in the pathogenesis of gastrointestinal diseases? Adv Anat Pathol 1999; 6:19–40.

    PubMed  Google Scholar 

  7. Erlandson RA, Klimstra DS, Woodruff JM. Subclassification of gastrointestinal stromal tumors based on evaluation by electron microscopy and immunohistochemistry. Ultrastruct Pathol 1996;20:373–93.

    PubMed  Google Scholar 

  8. Rumessen JJ, Thuneberg L. Pacemaker cells in the gastrointestinal tract: interstitial cells of Cajal. Scand J Gastroenterol Suppl 1996;216:82–94.

    PubMed  Google Scholar 

  9. Wester T, Eriksson L, Olsson Y, Olsen L. Interstitial cells of Cajal in the human fetal small bowel as shown by c-KIT immunohistochemistry. Gut 1999;44:65–71.

    PubMed  Google Scholar 

  10. Torihashi S, Nishi K, Tokutomi Y et al. Blockade of kit signaling induces transdifferentiation of interstitial cells of Cajal to a smooth muscle phenotype. Gastroenterology 1999;117:140–8.

    PubMed  Google Scholar 

  11. Kitamura Y, Hirota S, Nishida T. Molecular pathology of c-KIT proto-oncogene and development of gastrointestinal stromal tumors. Ann Chir Gynaecol 1998;87:282–6.

    PubMed  Google Scholar 

  12. Lasota J, Wozniak A, Sarlomo-Rikala M et al. Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases. Am J Pathol 2000;157:1091–5.

    PubMed  Google Scholar 

  13. Sakurai S, Hishima T, Takazawa Y et al. Gastrointestinal stromal tumors and KIT-positive mesenchymal cells in the omentum. Pathol Int 2001; 51:524–31.

    Article  PubMed  Google Scholar 

  14. Walker P, Dvorak AM. Gastrointestinal autonomic nerve (GAN) tumor. Ultrastructural evidence for a newly recognized entity. Arch Pathol Lab Med 1986; 110:309–16.

    PubMed  Google Scholar 

  15. Herrera GA, Cerezo L, Jones JE et al. Gastrointestinal autonomic nerve tumors. ‘Plexosarcomas’. Arch Pathol Lab Med 1989;113:846–53.

    PubMed  Google Scholar 

  16. Rosen RM. Familial multiple upper gastrointestinal leiomyoma. Am J Gastroenterol 1990;85:303–5.

    PubMed  Google Scholar 

  17. Clary BM, DeMatteo RP, Lewis JJ et al. Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparison. Ann Surg Oncol 2001;8:290–9.

    Google Scholar 

  18. Miettinen M, Lasota J. Gastrointestinal stromal tumors — definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001;438:1–12.

    PubMed  Google Scholar 

  19. Hansson LE, Sparen P, Nyren O. Stomach leiomyosarcoma: secular trends in incidence and survival in Sweden, 1960–1989. Scand J Gastroenterol 1998;33:540–3.

    Article  PubMed  Google Scholar 

  20. Chow JS, Chen CC, Ahsan H, Neugut AI. A populationbased study of the incidence of malignant small bowel tumours: SEER, 1973–1990. Int J Epidemiol 1996;25:722–8.

    PubMed  Google Scholar 

  21. Karnak I, Senocak ME, Ciftci AO et al. Inflammatory myofibroblastic tumor in children: diagnosis and treatment. J Pediatr Surg 2001;36:908–12.

    Article  PubMed  Google Scholar 

  22. Kim IH, Kim PS, Lee DH et al. Gastric malignant stromal tumor with long stalk impacted into duodenum. Yonsei Med J 1999;40:510–3.

    PubMed  Google Scholar 

  23. Shojaku H, Futatsuya R, Seto H et al. Malignant gastrointestinal stromal tumor of the small intestine: radiologic-pathologic correlation. Radiat Med 1997;15:189–92.

    PubMed  Google Scholar 

  24. Hama Y, Okizuka H, Odajima K et al. Gastrointestinal stromal tumor of the rectum. Eur Radiol 2001;11:216–9.

    Article  PubMed  Google Scholar 

  25. Tworek JA, Appelman HD, Singleton TP, Greenson JK. Stromal tumors of the jejunum and ileum. Mod Pathol 1997;10:200–9.

    PubMed  Google Scholar 

  26. Joensuu H, Roberts PJ, Sarlomo-Rikala M et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001;344:1052–6.

    PubMed  Google Scholar 

  27. Demetri GD, von Mehren M, Blanke CD et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347:472–80.

    Article  PubMed  Google Scholar 

  28. DeMatteo RP, Lewis JJ, Leung D et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000;231:51–8.

    Article  PubMed  Google Scholar 

  29. Emory TS, O’Leary TJ. Prognosis and surveillance of gastrointestinal stromal/smooth muscle tumors. Ann Chir Gynaecol 1998;87:306–10.

    PubMed  Google Scholar 

  30. Franquemont DW, Frierson HF Jr. Proliferating cell nuclear antigen immunoreactivity and prognosis of gastrointestinal stromal tumors. Mod Pathol 1995;8:473–7.

    PubMed  Google Scholar 

  31. Ueyama T, Guo KJ, Hashimoto H et al. A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors. Cancer 1992;69:947–55.

    PubMed  Google Scholar 

  32. Emory TS, Sobin LH, Lukes L et al. Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. Am J Surg Pathol 1999;23:82–7.

    Article  PubMed  Google Scholar 

  33. Carrillo R, Candia A, Rodriguez-Peralto JL, Caz V. Prognostic significance of DNA ploidy and proliferative index (MIB-1 index) in gastrointestinal stromal tumors. Hum Pathol 1997;28:160–5.

    Article  PubMed  Google Scholar 

  34. Cunningham RE, Abbondanzo SL, Chu WS et al. Apoptosis, bcl-2 expression, and p53 expression in gastrointestinal stromal/smooth muscle tumors. Appl Immunohistochem Mol Morphol 2001;9:19–23.

    PubMed  Google Scholar 

  35. Ernst SI, Hubbs AE, Przygodzki RM et al. KIT mutation portends poor prognosis in gastrointestinal stromal/ smooth muscle tumors. Lab Invest 1998;78:1633–6.

    PubMed  Google Scholar 

  36. Berman J, O’Leary TJ. Gastrointestinal stromal tumor workshop. Hum Pathol 2001;32:578–82.

    Article  PubMed  Google Scholar 

  37. DeMatteo RP, Lewis JJ, Leung D et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000;231:51–8.

    Article  PubMed  Google Scholar 

  38. Franquemont DW. Differentiation and risk assessment of gastrointestinal stromal tumors. Am J Clin Pathol 1995;103:41–7.

    PubMed  Google Scholar 

  39. Graadt van Roggen JF, van Velthuysen ML, Hogendoorn PC. The histopathological differential diagnosis of gastrointestinal stromal tumours. J Clin Pathol 2001;54:96–102.

    Article  PubMed  Google Scholar 

  40. Joensuu H, Fletcher C, Dimitrijevic S et al. Management of malignant gastrointestinal stromal tumours. Lancet Oncol 2002;3:655–64.

    PubMed  Google Scholar 

  41. Miettinen M, Lasota J. Gastrointestinal stromal tumors — definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001;438:1–12.

    PubMed  Google Scholar 

  42. Savage DG, Antman KH. Imatinib mesylate — a new oral targeted therapy. N Engl J Med 2002;346:683–93.

    Article  PubMed  Google Scholar 

  43. Tworek JA, Appelman HD, Singleton TP, Greenson JK. Stromal tumors of the jejunum and ileum. Mod Pathol 1997;10:200–9.

    PubMed  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag London Limited

About this chapter

Cite this chapter

Samel, S.T., Post, S. (2005). Stromal Upper GI Tract Neoplasms. In: Upper Gastrointestinal Surgery. Springer Specialist Surgery Series. Springer, London. https://doi.org/10.1007/1-84628-066-4_15

Download citation

  • DOI: https://doi.org/10.1007/1-84628-066-4_15

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-607-3

  • Online ISBN: 978-1-84628-066-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics